Document is current
Any future updates will be listed below
-
Authors
Margerie, Daniel
Lefebvre, Philippe
Raverdy, Violeta
Schwahn, Uwe
Ruetten, Hartmut
Larsen, Philip
Duhamel, Alain
Labreuche, Julien
Thuillier, Dorothée
Derudas, Bruno
Gheeraert, Céline
Dehondt, Hélène
Dhalluin, Quentin
Alexandre, Jérémy
Caiazzo, Robert
Nesslany, Pamela
Verkindt, Helene
Pattou, François
Staels, Bart https://orcid.org/0000-0002-3784-1503
-
Funding
Funding for this research was provided by:
ANR (ANR-10-LABX-46)
Fonds hospitalier d’aide à l’émergence et à la structuration des activités et des équipes de recherche (N/A)
ERC (694717)
Sanofi (N/A)
- License Information
-
More Information
Article History
Received: 13 December 2018
Accepted: 21 May 2019
First Online: 3 June 2019
Ethics approval and consent to participate
: Human liver biopsies were collected from patients undergoing surgery after informed consent was obtained. All procedures were approved by the C.H.R.U. Lille Ethical committee and were compliant to the French National Ethics Committee guidelines. The ABOS cohort is registered at with the following identifier: NCT01129297.
: Not applicable.
: Drs. Margerie, Schwahn, Ruetten and Larsen are employees and shareholders of Sanofi. All other authors declare no potential conflicts of interest relevant to this article.
